4//SEC Filing
Lee John Sang 4
Accession 0001209191-19-015044
CIK 0001169245other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 4:52 PM ET
Size
5.7 KB
Accession
0001209191-19-015044
Insider Transaction Report
Form 4
Lee John Sang
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2019-02-27+100,000→ 100,000 totalExercise: $3.15Exp: 2029-02-27→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest in equal monthly installments over 48 months from February 27, 2019, subject to the reporting person's continued service through each such date.
Documents
Issuer
PhaseBio Pharmaceuticals Inc
CIK 0001169245
Entity typeother
Related Parties
1- filerCIK 0001755665
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 4:52 PM ET
- Size
- 5.7 KB